Cisatracurium Besylate 70069-0141
Product NDC
70069-0141- Manufacturer
- Somerset Therapeutics, Llc
- Dosage Form
- Injection
- Route
- Intravenous
- Product Type
- Human Prescription Drug
- Marketing Start
- February 4, 2019
- Listing Expires
- December 31, 2027
- Application
- ANDA206791
Need to source Cisatracurium Besylate? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Cisatracurium Besylate | 2 mg/mL |
Drug Class
Neuromuscular Nondepolarizing Blockade [PE]Nondepolarizing Neuromuscular Blocker [EPC]
Packaging Options(2)
1 VIAL in 1 CARTON (70069-141-01) / 5 mL in 1 VIAL
10 VIAL in 1 CARTON (70069-141-10) / 5 mL in 1 VIAL